We have produced an antiserum that inhibits interleukin 1-mediated functions in immune responses. Skin graft-induced helper factor-containing supernatant (SgHFS) was used as immunogen in rats. The resultant antiserum was immunosuppressive of T-cell functions both in vivo and in vitro. We have further studied the effects of this antiserum on cell surface molecules that are involved in the generation of cytolytic effector T cells. Rat anti-SgHFS inhibited the differentiation of precytolytic effector cells in mixed lymphocyte cultures by blocking the helper-cell pathway. Both the level and the kinetics of interleukin 2 production were affected as the duration of rat anti-SgHFS pretreatment was increased. Interleukin 1 production after 24 hr in culture was unaffected. Monokines, including partially purified interleukin 1, actively compete with the rat anti-SgHFS by activating helper cells and thus circumvent suppression. Rat anti-SgHFS inhibits interleukin-l-mediated functions by a time-dependent active process. Thus, the target cell surface molecule(s) affected by the rat anti-SgHFS are associated with interleulkin 1 function and may be the interleukin 1 receptor.
The generation of cytolytic T lymphocytes (CTL) involves a series of distinct cellular and soluble protein interactions that can be readily divided into two pathways: (l) activation of the helper T-cell pathway and subsequent release of helper/ differentiation factors and (ii) activation and differentiation of precursor cytolytic T cells. The helper T-cell pathway is activated by at least two signals: antigen and interleukin 1 (IL-1) (1-3). The cytolytic T-cell pathway precursors require antigen and helper signals in order to differentiate into cytolytic T cells (4, 5) . The role of IL-1 in the precytolytic pathway has not been defined. In the antigen-primed helper Tcell pathways, IL-1 serves as a necessary signal to trigger the production of interleukin 2 (IL-2) (2) and for the expression of IL-2 receptors (29) . IL-2, also called T-cell growth factor, supports the proliferative expansion of antigen-activated cells both in the helper T-cell pathway and in CTL differentiation (6, 7) . Other lymphokine/monokine factors besides IL-1 and IL-2 are required for the generation of CTL (4, 5, (8) (9) (10) (11) (12) (13) (14) . The role of IL-1 in the production of these other lymphokines/monokines has not been determined.
One approach used to study the pathway of CTL differentiation has been to generate antiserum or monoclonal antibodies against antigen-primed T cells or their secreted/shed products. These antibodies are then used to further define the cell surface structure(s) involved in cell-cell collaboration as well as the function of various soluble factors involved in the differentiation of CTL. The contribution of a number of cell surface markers in both human and murine CTL activities as well as the lymphokine IL-2 have been studied using this approach (15) (16) (17) (18) (19) (20) (21) .
We have described an antiserum that was raised in rats against skin graft-induced helper factor-containing supernatant (SgHFS) and have utilized this rat anti-SgHFS to examine the differentiation pathways of precytolytic effector T cells (11, 22) . The 2D ). These findings are also reproducible with other strain combinations (unpublished results).
Cultures then were set up in which aliquots of responder cells were pretreated with normal rat serum or rat antiSgHFS for intervals ranging from 5 min to 4 hr. The inhibition of CTL generation was greater as the pretreatment time was increased (Fig. 3) , suggesting therefore that the rat antiSgHFS modulates a membrane-associated function required for CTL generation.
Effects of Rat Anti-SgHFS on Production of IL-1 and IL-2. Antigen-priming and IL-1 activation of the helper T-cell pathway are two of the earliest known events associated with active membrane processes. Antigen-priming of precytolytic T cells does occur in the presence of the rat antiSgHFS, as shown by the generation of CTL after the addition of RCAS. We thus quantitated the levels of IL-1 and IL-2 produced to determine whether the rat anti-SgHFS had an effect on helper T-cell activation. At various times after the responder cells had been pretreated with rat anti-SgHFS, washed, and cultured with -irradiated stimulator cells, the contents of the culture wells were pooled, the cells were removed, and the supernatants were assayed for IL-1 and IL-2 activities. A progressive decrease in cytolytic activity was observed again with increasing duration of antiserum pretreatment (Table 1) . No significant differences in IL-1 levels were detected in supernatants collected 24 hr after the initiation of culture. No IL-2 activity was detectable at 24 hr in assays with the IL-2-dependent cell line; therefore, we concluded that the thymocyte proliferation assay on 24-hr supernatant indeed was measuring an effect of IL-i. At later time points, however, IL-2 was detected, so that IL-1 levels at these times could not be accurately measured in the thymocyte proliferation assay. A marked effect on IL-2 production (Fig. 4 A and B) or FS6-14.13 lymphokine supernatant before pretreatment with the rat anti-SgHFS. CTL were generated only in cultures that had been incubated with P388D1 supernatant before pretreatment with rat anti-SgHFS (Fig. 6A) . Preincubation of responder cells with lymphokines had no effect. Results similar to these were obtained when either rat antiSgHFS and P388D1 supernatant or rat anti-SgHFS and FS6-14.13 supernatant were mixed together before pretreatment (Fig. 6B) Proc. Nad Acad Sd USA 82 (1985) Proc. NatL. Acad. Scd USA 82 (1985) 1517 the inhibitory effect, whereas preincubation with lymphokine-containing supernatants did not.
Effect of Purified IL-1 on Rat Anti-SgHFS Pretreatment. The crude P388D1 supernatants may contain a number of monokines that affect membrane-associated processes. Therefore, we preincubated the responder cells in the presence of purified human IL-1. In two separate experiments, purified human IL-1 was able to overcome the inhibitory effect of rat anti-SgHIFS (Fig. 7) . CTL activity obtained in cultures pretreated with rat anti-SgHFS and purified IL Further studies demonstrated that although these cells had becqme unresponsive to insulin, they remained responsive to other stimulants such as spermine and vitamin K5 (4-amino-2-methyl-1-naphthol) (26) (27) (28) . Conclusive evidence that we indeed have been able to generate antibodies directed against the IL-1 receptor must await either the availability of radiolabeled purified IL-1 or the production of a monoclonal antibody. It is clear, however, that the rat anti-SgHFS recognizes molecules associated with IL-1 functions in CTL responses. We should point out too that the antiserum has immunosuppressive effects in vivo and prolongs median skin graft survival times (22) .
The data presented herein also suggest that the rat antiSgHFS directly inhibits the helper pathway as opposed to the precytolytic-T-cell differentiation pathway. The addition of several nonspecific helper factor-and IL-2-pqntaining supernatants to rat anti-SgHFS-pretreated responders resulted in the generation of cytolytic effectors. The precursor cells, therefore, had become activated by antigen despite the pretreatment with antiserum.
An effect of the rat anti-SgHFS on the helper pathway was further evidenced by the substantial decrease in the quantity of IL-2 detected. The fact that the IL-i levels produced after 24 hr in culture were equal to control levels indicated that the activation of macrophages to produce this monokine was unaffected. We conclude that IL-i-induced synthesis of IL-2 was blocked.
The addition of exogenous lymphokines circumvented the inhibition of IL-i-mediated function, but addition of macrophage-cell line products could not. In further experiments (data not included) we added irradiated antigen-primed cells to rat anti-SgHFS-pretreated responders and were able to recover functional cytolytic effectors. These data again support the conclusion that the rat anti-SgHFS directly inhibited the helper pathway and not the pre-effector cell pathway. The inhibition of CTL generation by the rat anti-SgHFS, therefore, resulted from a lack of adequate helper signals. Our data clearly support other published reports of a requirement for IL-1 in helper-cell activation and, moreover, suggest that IL-1 is not required as a direct signal in the precytolytic-T-cell differentiation pathway.
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